M. Bataller

发表

Circumvention of the multidrug-resistance protein (MRP-1) by an antitumor drug through specific inhibition of gene transcription in breast tumor cells.

W. Priebe, Sylvia Mansilla, Marta Rojas, 2007, Biochemical pharmacology.

Mitotic catastrophe as a consequence of chemotherapy.

M. Bataller, J. Portugal, S. Mansilla, 2006, Anti-cancer agents in medicinal chemistry.

Apoptosis and cell recovery in response to oxidative stress in p53-deficient prostate carcinoma cells.

M. Bataller, J. Portugal, 2005, Archives of biochemistry and biophysics.

Cellular response and activation of apoptosis by mithramycin SK in p21(WAF1)-deficient HCT116 human colon carcinoma cells.

C. Méndez, J. Salas, M. Bataller, 2010, Cancer letters.

Mithramycin SK modulates polyploidy and cell death in colon carcinoma cells

C. Méndez, J. Salas, M. Bataller, 2008, Molecular Cancer Therapeutics.

Mechanisms of drug-induced mitotic catastrophe in cancer cells.

M. Bataller, J. Portugal, S. Mansilla, 2010, Current pharmaceutical design.

Cell Death Pathways in Response to Antitumor Therapy

M. Bataller, J. Portugal, S. Mansilla, 2009, Tumori.

Cell death pathways in response to antitumor therapy.

M. Bataller, J. Portugal, S. Mansilla, 2009, Tumori.

A nuclear budding mechanism in transiently arrested cells generates drug-sensitive and drug-resistant cells.

M. Bataller, J. Portugal, S. Mansilla, 2009, Biochemical pharmacology.